Publications by authors named "Hilda Fernandez Ovalle"
Article Synopsis
- Early identification of patients at high risk for severe COVID-19 is critical, and this study focused on the relationship between mid-regional proadrenomedullin (MR-proADM), a biomarker of endothelial dysfunction, and patient outcomes.
- In a cohort of 99 COVID-19 patients, MR-proADM was found to be a strong predictor of 28-day mortality and progression to severe disease, outperforming other biomarkers in accuracy.
- The study concluded that elevated levels of MR-proADM are significantly associated with higher mortality and disease severity risk, suggesting it could be a valuable tool for early prognosis in COVID-19 cases.
Background: ADIPOQ rs266729 have been associated with body mass index and metabolic parameters.
Objectives: Our aim was to assess the contribution of this genetic variant on lipid profile and serum adiponectin levels after biliopancreatic diversion surgery in morbidly obese patients in a 3-year prospective study.
Setting: Tertiary Hospital.
Background And Aims: The aim of this study was to determine the association of single nucleotide polymorphism rs1501299 in the ADIPOQ gene with body weight, insulin resistance, serum adipokine levels and metabolic syndrome (MetS).
Methods: The study involved a population of 1,007 adult obese subjects. Parameters like body weight, fat mass, waist circumferences, blood pressure, fasting blood glucose, C-reactive protein, insulin concentration, homeostasis model assessment for insulin resistance (HOMA-IR), lipid profile and adipocytokines levels (leptin, adiponectin and resistin) were all measured.